Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial.
Park JO, Feng YH, Su WC, Oh DY, Keam B, Shen L, Kim SW, Liu X, Liao H, Qing M, Zhang C, Qian J, Tang X, Li P, Triantos S, Sweiti H.
Park JO, et al. Among authors: li p.
BMC Cancer. 2024 Aug 13;24(1):1006. doi: 10.1186/s12885-024-12584-0.
BMC Cancer. 2024.
PMID: 39138436
Free PMC article.
Clinical Trial.